Industry NewsAstraZeneca progresses Ambition Zero Carbon program with Honeywell partnership to develop next-generation respiratory inhalers
Industry NewsAZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Industry NewsNew sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits
Industry NewsAstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
Industry NewsTagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Industry NewsPhase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
Industry NewsNirsevimab reduced respiratory syncytial virus infections and hospitalizations in preterm infants in Phase IIb trial
Industry NewsAstraZeneca, Oxford University COVID-19 vaccine shows robust immune responses in Phase I/II trial
Industry NewsAstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine
Product NewsStudy Confirms that InSphero Human Liver Microtissue is Better at Predicting Drug-induced Liver Injury
Industry NewsMRC Technology, AstraZeneca, Asthma UK and British Lung Foundation Enter into Collaboration to Explore Novel Treatments for Respiratory Diseases
Industry NewsNew Cell Study Presents Ground-breaking Pre-Clinical Work: Developing Immune Therapy to Potentially Treat Serious Influenza A
Industry NewsAstraZeneca Collaborates with Cambridge Medical Research Institutions to Advance Cancer Research
